Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Gunilla Osswald

Tracked across 5 events · 32 articles · First seen Apr 21, 2026 · Last active Sep 22, 2026

Sentiment
3
Attention
2
Events
5
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 0
Business
Impact: Gunilla Osswald, CEO of BioArctic, will present and comment on the first quarter report during the webcast and teleconference.
May 13, 2026 · 7 articles
2 10
Business
Impact: As CEO of BioArctic, Gunilla Osswald announced the collaboration, representing BioArctic's strategic move into oncology.
Aug 19, 2026 · 6 articles
2 5
Tech
BioArctic announced that Leqembi (lecanemab), the first therapy targeting an underlying cause of Alzheimer's disease, is now available at a private clinic in Sweden and that the first patient has started treatment. This marks the…
Impact: Gunilla Osswald, CEO of BioArctic, commented on the significance of bringing Leqembi to Swedish patients and highlighted the unmet need in early Alzheimer's disease.
Sep 22, 2026 · 7 articles
0 0
Business
Impact: CEO Gunilla Osswald will present the Q2 results during the webcast. Her role is standard for an earnings call.
Aug 19, 2026 · 6 articles
2 0
Business
Apr 21, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Gunilla Osswald live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.